Laserfiche WebLink
INTERMEDIX HOLDINGS INC. AND SUBSIDIARIES <br />Notes to Consolidated Financial Statements <br />December 31, 2010 <br />platforms and to its enterprise cloud computing application services as well as for modifications to <br />existing computer software that result in additional functionality. These costs are included in <br />"Computer software and technology development costs, net" in the accompanying consolidated <br />balance sheet. <br />Costs incurred for the development of internal -use software largely consist of payroll and <br />payroll - related costs for employees and consultants who are directly associated with and who devote <br />time to the internal -use computer software projects. Such costs are expensed until (i) the preliminary <br />project stage is completed, (ii) management has authorized and committed funding for the project, <br />and (iii) it is probable that the project will be completed and the software will be used to perform the <br />function intended, at which time,. in accordance with ASC Topic 350 -40, any additional software <br />development costs are capitalized. Capitalization ceases when a computer software project is <br />substantially complete and ready for its intended use. <br />Amortization of internally developed computer software, which is included in "Depreciation and <br />amortization expense," begins when the computer software is ready for its intended use. These costs <br />are amortized over the period which the asset is expected to contribute directly or indirectly to future <br />cash flow. The Company generally amortizes internally developed software on a straight -line basis <br />over a five year period and periodically reassesses the estimated useful lives of its internally <br />developed software in consideration of, among other factors, the effects of (i) obsolescence, <br />(ii) technology, (iii) competition, and (iv) other economic factors. <br />The Company assesses the recoverability of computer software development costs by comparing the <br />carrying amount to the fair value whenever events or changes in circumstances indicate that its <br />carrying amount may not be recoverable. The carrying amount is not recoverable if it exceeds the <br />sum of the undiscounted cash flows expected to result from the use and eventual disposition of the <br />asset or asset group. An impairment loss is recognized if the carrying amount exceeds the fair value. <br />In determining fair value of internally developed computer software, the Company considers whether <br />(i) it is expected to provide continued substantive service potential, (ii) significant changes in the <br />extent or manner in which the software is used or is expected to be used, (iii) it is or is expected to <br />undergo a significant change, or (iv) projected development or modification costs significantly <br />exceed original estimates. <br />Also included in "Computer Software and Technology Development Costs, net" is software <br />purchased from third parties. <br />(h) Goodwill and Intangible Assets <br />Goodwill is recorded in accordance with ASC Topic 805, when the consideration paid for an <br />acquisition exceeds the fair value of identifiable net tangible and identifiable intangible assets <br />acquired. In accordance with ASC Topic 350, Intangibles — Goodwill and Other (ASC Topic 350) <br />goodwill and other indefinite -lived intangible assets are reviewed for impairment at least annually. <br />The Company has elected to perform its annual impairment testing as of October 31 of each year and <br />as required should any triggering events occur indicating a potential for impairment. Given the close <br />proximity of the fair value measurements performed on the Merger Date in relation to the date of the <br />accompanying consolidated balance sheet, and due to the absence of any triggering events during the <br />Successor period, no impairment testing was deemed necessary for the current year. <br />10 (Continued) <br />